3B BlackBio Dx (BOM:532067) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 3B BlackBio Dx's Free Cash Flow for the three months ended in Dec. 2023 was ₹0.0 Mil. 3B BlackBio Dx's Revenue for the three months ended in Dec. 2023 was ₹176.7 Mil. Therefore, 3B BlackBio Dx's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, 3B BlackBio Dx's current FCF Yield % is 3.04%.

The historical rank and industry rank for 3B BlackBio Dx's FCF Margin % or its related term are showing as below:

BOM:532067' s FCF Margin % Range Over the Past 10 Years
Min: -6.44 Med: 7.98 Max: 43.48
Current: 30.16

During the past 13 years, the highest FCF Margin % of 3B BlackBio Dx was 43.48%. The lowest was -6.44%. And the median was 7.98%.

BOM:532067's FCF Margin % is ranked better than
95.03% of 1047 companies
in the Biotechnology industry
Industry Median: -145.04 vs BOM:532067: 30.16

3B BlackBio Dx FCF Margin % Historical Data

The historical data trend for 3B BlackBio Dx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx FCF Margin % Chart

3B BlackBio Dx Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

12.25

22.53

42.27

43.48

33.77

3B BlackBio Dx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of 3B BlackBio Dx's FCF Margin %

For the Biotechnology subindustry, 3B BlackBio Dx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3B BlackBio Dx's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's FCF Margin % falls into.

3B BlackBio Dx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

3B BlackBio Dx's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	208.801	/	618.36
	=	33.77 %

3B BlackBio Dx's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	176.689
	=	0.00 %

3B BlackBio Dx FCF Margin % Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

3B BlackBio Dx (BOM:532067) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023

Website

https://www.3bblackbio.com

3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines